Angle P, Landy CK, Djordjevic J et al.
Therapeutic area: Nervous System Diseases, Pathological Conditions, Signs and Symptoms
To measure the most important dimensions of women's childbirth pain experiences using 5 subscales: The Enormity of the Pain, Fear/Anxiety, Uterine Contraction Pain, Birthing Pain and Back Pain/Long Haul.
Albert Steven M, PhD, MSPH
Therapeutic area: Nervous System Diseases, Mental Disorders
To assess quality of life in dementia
Mapi
Therapeutic area: Generic
The ACCEPT© questionnaire is a generic medication acceptance measure assessing how patients weigh advantages and disadvantages of long-term medications. ACCEPT© may be a predictor of patients' future adherence to and/or persistence with their treatment.
Juniper Elizabeth, MCSP, Msc
Therapeutic area: Respiratory Tract Diseases, Immune System Diseases
To measure the adequacy of clinical asthma control
Juniper Elizabeth, MCSP, Msc
Therapeutic area: Respiratory Tract Diseases, Immune System Diseases
To measure the adequacy of clinical asthma control
Cano Stefan, Lamping Donna L
Therapeutic area: Cardiovascular Diseases, Respiratory Tract Diseases
To measure patient treatment satisfaction with anticoagulation treatment
Novartis Pharmaceuticals Corporation, Mapi
Therapeutic area: Nervous System Diseases, Mental Disorders
To assess caregivers' satisfaction with and preference for patch or capsule treatments in Alzheimer’s Disease patients
Juniper Elizabeth, MCSP, Msc
Therapeutic area: Eye Diseases, Otorhinolaryngologic Diseases, Respiratory Tract Diseases
To measure the functional impairments that are most troublesome to patients between the ages of 12 and 17 years as a result of their rhinoconjunctivitis
Otsuka Pharmaceutical Development & Commercialization, Inc (USA)
Therapeutic area: Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases
To measure the impact of ADPKD on patients’ lives
Otsuka Pharmaceutical Development & Commercialization, Inc (USA)
Therapeutic area: Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases
To understand the disease-specific burden of pain and discomfort due to ADPKD
Black Betty S, Kasper Judith D, Rabins Peter V
Therapeutic area: Nervous System Diseases, Mental Disorders
To evaluate treatment interventions in Alzheimer's Disease
Sanofi Aventis
Therapeutic area: Nutritional and Metabolic Diseases, Diagnosis, Pathological Conditions, Signs and Symptoms, Physiological Phenomena
To measure adherence to a healthy lifestyle (diet and exercise; motivation, barriers, results, satisfaction, adherence to lifestyle changes)
Sanofi Aventis
Therapeutic area: Pathological Conditions, Signs and Symptoms
To record patients’ daily experiences of symptoms that trigger a request for a paracentesis in patients with ascites
Sanofi Aventis
Therapeutic area: Otorhinolaryngologic Diseases
To capture data on the child’s daily level of Acute Otitis Media (AOM) symptom severity and to systematically assess resolution of symptoms
Juniper Elizabeth, MCSP, Msc
Therapeutic area: Respiratory Tract Diseases, Immune System Diseases
To measure the functional impairments that are most troublesome to adults (17-70 years) as a result of their asthma
Pfizer (France), Mapi
Therapeutic area: Musculoskeletal Diseases
To assess patient satisfaction with their osteoarthritis (OA) treatment
The European Restless Legs Syndrome Study Group (EURLSSG)
Therapeutic area: Nervous System Diseases, Mental Disorders
To assess severity of augmentation, the main complication during long-term dopaminergic treatment of restless legs syndrome (RLS)
Dazord Alice, Manificat Sabine
Therapeutic area: Generic
To assess the child’s subjective Quality of Life
Jones SD, Steiner A, Garrett SL et al.
Therapeutic area: Musculoskeletal Diseases
To reflect the effect of ankylosing spondylitis (AS) on the patient's well-being
Calin Andrei
Therapeutic area: Musculoskeletal Diseases
To define disease activity in patients with ankylosing spondylitis